Epilepsy is a globally prevalent neurological condition associated with mood disorders such as depression and bipolar disorder. This study analyzed the prevalence of and hazard ratios for mood disorders, as well as risk factors, among patients with newly diagnosed epilepsy using a comprehensive South Korean national health database.
Method
Health insurance and health examination data (2004-2013) were utilized in this retrospective cohort study. Patients newly diagnosed with epilepsy based on International Classification of Diseases-10th revision codes and without a mood disorder history were included. Mean follow-up duration was 3.6 years and 4.1 years for the epilepsy and control cohorts, respectively. Cox proportional hazards models adjusted for demographic and health variables were used to estimate the risk of developing mood disorders post-epilepsy diagnosis.
Results
A total of 2210 patients with epilepsy and 22,100 matched controls without epilepsy were included. Those with epilepsy exhibited a 3-fold increased risk of developing mood disorders compared with controls (incidence rate ratio: 3.10 [95% confidence interval (CI): 2.75-3.49]). The risk was highest in the first two years post-diagnosis (adjusted hazard ratio: 3.42 [95% CI: 2.90-4.03]). A notable increase in risk was also observed 8-10 years post-diagnosis (adjusted hazard ratio: 3.07 [(95% CI: 1.14-8.22]), indicating a sustained long-term risk.
Conclusions
Epilepsy significantly increases the risk of mood disorders, with the highest risk observed shortly after diagnosis. Continuous monitoring and tailored interventions are essential for managing patients’ mental health. Integrated care approaches are needed to treat epilepsy and associated mood disorders.
ShanTZhuYFanH, et al.Global, regional, and national time trends in the burden of epilepsy, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study. Front Neurol. 2024;15:1418926. doi:10.3389/fneur.2024.1418926
2.
MaguireJ. Mechanisms of psychiatric comorbidities in epilepsy. Curr Top Behav Neurosci. 2022;55:107-144. doi:10.1007/7854_2020_192
3.
KesslerRCChiuWTDemlerOMerikangasKRWaltersEE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:617-627. doi:10.1001/archpsyc.62.6.617
4.
LuEPyatkaNBurantCJSajatovicM. Systematic literature review of psychiatric comorbidities in adults with epilepsy. J Clin Neurol. 2021;17:176-186. doi:10.3988/jcn.2021.17.2.176
5.
KannerAM. Depression in epilepsy: a neurobiologic perspective. Epilepsy Curr. 2005;5:21-27.
6.
VezzaniABalossoSRavizzaT. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol. 2019;15:459-472.
7.
KannerAM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54:388-398. doi:10.1016/s0006-3223(03)00469-4
8.
TaylorRSSanderJWTaylorRJBakerGA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011;52:2168-2180. doi:10.1111/j.1528-1167.2011.03213.x
9.
CramerJABlumDReedMFanningKEpilepsy Impact Project Group. The influence of comorbid depression on seizure severity. Epilepsia. 2003;44:1578-1584. doi:10.1111/j.0013-9580.2003.28403.x
10.
KnottSFortyLCraddockNThomasRH. Epilepsy and bipolar disorder. Epilepsy Behav. 2015;52:267-274. doi:10.1016/j.yebeh.2015.07.003
11.
ChuC. Association between epilepsy and risk of depression: a meta-analysis. Psychiatry Res. 2022;312:114531. doi:10.1016/j.psychres.2022.114531
12.
GlosserGZwilASGlosserDSO'ConnorMJSperlingMR. Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomy. J Neurol Neurosurg Psychiatry. 2000;68:53-58. doi:10.1136/jnnp.68.1.53
13.
Koch-WeserMGarronDCGilleyDW, et al.Prevalence of psychologic disorders after surgical treatment of seizures. Arch Neurol. 1988;45:1308-1311. doi:10.1001/archneur.1988.00520360026006
14.
SilbermanEKSussmanNSkillingsGCallananM. Aura phenomena and psychopathology: a pilot investigation. Epilepsia. 1994;35:778-784. doi:10.1111/j.1528-1157.1994.tb02511.x
15.
VictoroffJ. DSM-III—R psychiatric diagnoses in candidates for epilepsy surgery: lifetime prevalence. Neuropsychiatry, Neuropsychology, & Behavioral Neurology. 1994;7:87-97.
16.
JacobyABakerGASteenNPottsPChadwickDW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia. 1996;37:148-161. doi:10.1111/j.1528-1157.1996.tb00006.x
17.
ElwesRDMarshallJBeattieANewmanPK. Epilepsy and employment. A community based survey in an area of high unemployment. J Neurol Neurosurg Psychiatry. 1991;54:200-203. doi:10.1136/jnnp.54.3.200
18.
ShackletonDPKasteleijn-Nolst TrenitéDGde CraenAJVandenbrouckeJPWestendorpRGJ. Living with epilepsy: long-term prognosis and psychosocial outcomes. Neurology. 2003;61:64-70. doi:10.1212/01.wnl.0000073543.63457.0a
19.
BakerGAJacobyABuckDStalgisCMonnetD. Quality of life of people with epilepsy: a European study. Epilepsia. 1997;38:353-362. doi:10.1111/j.1528-1157.1997.tb01128.x
20.
HesdorfferDCHauserWAAnnegersJFCascinoG. Major depression is a risk factor for seizures in older adults. Ann Neurol. 2000;47:246-249.
21.
HesdorfferDCHauserWAOlafssonELudvigssonPKjartanssonO. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59:35-41. doi:10.1002/ana.20685
22.
HesdorfferDCIshiharaLMynepalliLWebbDJWeilJHauserWA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72:184-191. doi:10.1002/ana.23601
23.
JosephsonCBJettéN. Psychiatric comorbidities in epilepsy. Int Rev Psychiatr. 2017;29:409-424. doi:10.1080/09540261.2017.1302412
24.
OttmanRLiptonRBEttingerAB, et al.Comorbidities of epilepsy: results from the epilepsy comorbidities and health (EPIC) survey. Epilepsia. 2011;52:308-315. doi:10.1111/j.1528-1167.2010.02927.x
25.
ChangH-JLiaoC-CHuC-JShenWWChenTL. Psychiatric disorders after epilepsy diagnosis: a population-based retrospective cohort study. PLoS One. 2013;8:e59999. doi:10.1371/journal.pone.0059999
26.
EttingerABReedMLGoldbergJFHirschfeldRMA. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology. 2005;65:535-540. doi:10.1212/01.wnl.0000172917.70752.05
27.
Fuller-ThomsonEBrennenstuhlS. The association between depression and epilepsy in a nationally representative sample. Epilepsia. 2009;50:1051-1058. doi:10.1111/j.1528-1167.2008.01803.x
28.
EttingerAReedMCramerJEpilepsy Impact Project Group. Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology. 2004;63:1008-1014. doi:10.1212/01.wnl.0000138430.11829.61
29.
LiuZYinRFanZ, et al.Gender differences in associated and predictive factors of anxiety and depression in people with epilepsy. Front Psychiatr. 2020;11:670, doi:10.3389/fpsyt.2020.00670
30.
LorantVDeliègeDEatonWRobertAPhilippotPAnsseauM. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003;157:98-112.
31.
PatelVSaxenaSLundC, et al.The Lancet Commission on global mental health and sustainable development. Lancet. 2018;392:1553-1598.
32.
FluhartyMTaylorAEGrabskiMMunafòMR. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res. 2016;19:3-13.
33.
TaylorGMcNeillAGirlingAFarleyALindson-HawleyNAveyardP. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (Int Ed). 2014;348:g1151.
34.
JokelaMBattyGDNybergST, et al.Personality and all-cause mortality: individual-participant meta-analysis of 3,947 deaths in 76,150 adults. Am J Epidemiol. 2013;178:667-675.
35.
LoringDWMeadorKJLeeGP. Determinants of quality of life in epilepsy. Epilepsy Behav. 2004;5:976-980. doi:10.1016/j.yebeh.2004.08.019
36.
MulaMSanderJW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007;30:555-567. doi:10.2165/00002018-200730070-00001
37.
FatoyeFMosakuKSKomolafeMAdewuyaAO. Interictal anxiety and depression symptoms in Nigerians with epilepsy: a controlled study. Epilepsy Behav. 2006;9:312-316. doi:10.1016/j.yebeh.2006.05.007
38.
Fela-ThomasAAkinhanmiAEsanO. Prevalence and correlates of major depressive disorder (MDD) among adolescent patients with epilepsy attending a Nigerian neuropsychiatric hospital. Epilepsy Behav. 2016;54:58-64. doi:10.1016/j.yebeh.2015.11.008
39.
KwongKLLamDTsuiS, et al.Anxiety and depression in adolescents with epilepsy. J Child Neurol. 2016;31:203-210. doi:10.1177/0883073815587942
40.
OgunrinOAObiaboYO. Depressive symptoms in patients with epilepsy: analysis of self-rating and physician's assessment. Neurol India. 2010;58:565-570. doi:10.4103/0028-3886.68679
41.
OwolabiSDOwolabiLFUdofiaOSaleS. Depression in patients with epilepsy in Northwestern Nigeria: prevalence and clinical correlates. Ann Afr Med. 2016;15:179-184. doi:10.4103/1596-3519.194279
42.
LibrizziLNoèFVezzaniAde CurtisMRavizzaT. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol. 2012;72:82-90. doi:10.1002/ana.23567
43.
AlsaadiTEl HammasiKShahrourTM, et al.Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: a cross-sectional study. Epilepsy Behav. 2015;52:194-199. doi:10.1016/j.yebeh.2015.09.008
44.
HautSRVouyiouklisMShinnarS. Stress and epilepsy: a patient perception survey. Epilepsy Behav. 2003;4:511-514. doi:10.1016/s1525-5050(03)00182-3
45.
HautSRHallCBMasurJLiptonRB. Seizure occurrence: precipitants and prediction. Neurology. 2007;69:1905-1910. doi:10.1212/01.wnl.0000278112.48285.84
46.
HitirisNMohanrajRNorrieJSillsGJBrodieMJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75:192-196. doi:10.1016/j.eplepsyres.2007.06.003
47.
PetrovskiSSzoekeCEJonesNC, et al.Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology. 2010;75:1015-1021. doi:10.1212/WNL.0b013e3181f25b16
48.
FazelSWolfALångströmNNewtonCRLichtensteinP. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet. 2013;382:1646-1654. doi:10.1016/s0140-6736(13)60899-5
49.
JohnsonEKJonesJESeidenbergMHermannBP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia. 2004;45:544-550. doi:10.1111/j.0013-9580.2004.47003.x
50.
KannerAMBalabanovA. Depression and epilepsy. Neurology. 2002;58:S27-S39. doi:10.1212/WNL.58.8_suppl_5.S27
51.
ShenHZhangLXuCZhuJChenMFangY. Analysis of misdiagnosis of bipolar disorder in an outpatient setting. Shanghai Arch Psychiatry. 2018;30:93-101. doi:10.11919/j.issn.1002-0829.217080
